References
Alter, H. J. Chronic consequences of non-A, non-B hepatitis. In:Seeff, L., Lewis, J. H. (eds.): Current perspectives in hepatology. Plenum Medical, New York 1989, pp. 83–97.
Tassopoulos, N. C., Alikiotis, M., Limotirakis, F., Nikolakakis, P., Mela, H., Paraloglou-Ioannides, M. Acute sporadic non-A, non-B hepatitis in Greece. J. Med. Virol. 26 (1988) 71–77.
Tassopoulos, N. C., Hatzakis, A., Delladetsima, I., Koutelou, M. G., Todoulos, A., Miriagou, V. Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: a five-year prospective study. Gastroenterology 102 (1992) 969–972.
Davis, G. L., Balart, L. A., Schiff, E. R., Lindsay, K., Bodenheimer, H. C., Perrillo, R. P., Carey, W., Jacobson, I. M., Payne, J., Dienstag, J. L., Vanthiel, D. H., Tamburro, C., Lefkowitch, J., Albrecht, J., Meschievitz, C., Ortego, T. J., Gibas, A. Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial. N. Engl. J. Med. 321 (1989) 1501–1506.
Omata, M., Yokosuka, O., Takano, S., Kato, N., Hosoda, K., Imazeki, F., Tada, M., Ito, Y., Ohto, M. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 338 (1991) 914–915.
Tassopoulos, N. C., Hadziyiannis, S. J., Wright, G. E. A randomized double-blind placebo-controlled trial of α-interferon in acute type B hepatitis. Hepatology 10 (1989) 576.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tassopoulos, N.C., Koutelou, M., Papatheodoridis, G. et al. Treatment of acute non-A, non-B hepatitis with interferon alpha-2b. Infection 20, 242 (1992). https://doi.org/10.1007/BF02033074
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02033074